2020 Virtual ESMO Review
2020 ESMO Update on Immune Checkpoint Inhibitors in eTNBC: Does the Addition of Atezolizumab to Chemotherapy Improve pCR Rate in Neoadjuvant Setting?
By
2020 Virtual ESMO Review
FEATURING
Lee Schwartzberg
By
2020 Virtual ESMO Review
FEATURING
Lee Schwartzberg
Comments 1
Login to view comments.
Click here to Login
